Pharmerica (PMC) Guides FY12 Sales Below the Street

February 9, 2012 4:26 PM EST
Pharmerica (NYSE: PMC) sees FY12 sales of $1.92-$1.95 billion and EPS of $1.05-$1.28. The Street is currently expecting sales of $2.03 billion and EPS of $1.11.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Guidance